Patents by Inventor Nicholas Andrew MARZE

Nicholas Andrew MARZE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD1a ANTIBODIES AND USES THEREOF
    Publication number: 20240076382
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: July 19, 2023
    Publication date: March 7, 2024
    Applicants: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian WINAU, Oleg V. KOVALENKO, Chew Shun CHANG, Di WU, Nicholas Andrew MARZE, Shian-Huey CHIANG
  • ANTI- IL27R ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20240052047
    Abstract: The present invention relates to antibodies that specifically bind to one or both of IL27RA and gp130. The present invention further relates to bispecific antibodies that specifically bind to IL27RA and gp130. The present invention also pertains to related molecules, e.g. nucleic acids which encode such antibodies or bispecific antibodies, compositions, and related methods, e.g.
    Type: Application
    Filed: August 1, 2023
    Publication date: February 15, 2024
    Inventors: Yijie GAO, Nicholas Andrew MARZE, Laird BLOOM
  • ANTI-TNFR2 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230406951
    Abstract: The present disclosure provides antibodies that bind to TNFR2 as well as uses of the antibodies and associated methods. The disclosure also provides processes for making, preparing, and producing antibodies that bind to TNFR2. Antibodies of the disclosure are useful in one or more of diagnosis, prophylaxis, or treatment of disorders or conditions mediated by, or associated with, TNFR2 activity.
    Type: Application
    Filed: May 25, 2023
    Publication date: December 21, 2023
    Inventors: Todd Douglas ASHWORTH, Yue LIU, Nicholas Andrew MARZE, Virginie MCMANUS
  • CD1a antibodies and uses thereof
    Patent number: 11746154
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: October 7, 2021
    Date of Patent: September 5, 2023
    Assignees: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian Winau, Oleg V. Kovalenko, Chew Shun Chang, Di Wu, Nicholas Andrew Marze, Shian-Huey Chiang
  • CD1a ANTIBODIES AND USES THEREOF
    Publication number: 20220112291
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: October 7, 2021
    Publication date: April 14, 2022
    Applicants: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian WINAU, Oleg V. KOVALENKO, Chew Shun CHANG, Di WU, Nicholas Andrew MARZE, Shian-Huey CHIANG